UNSPSC 51282300: Erythromycins

This classification denotes an antibiotic variety based on a bacteriostatic produced from Streptomyces erythreus, hence the name ERYTHROMYCIN, and of which Erythromycin A is the major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.

UNSPSC 51282300 Erythromycins is a Class code that encompasses pharmaceutical products and related medical supplies state and local governments procure for community health, emergency response, and pharmacy benefit programs. Recent solicitations show state and local buyers purchasing naloxone and drug deactivation systems, medical and first aid supplies for emergency services, and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing arrangements. Issuing bodies include county health departments, municipal fire departments, state health and human services commissions, and multistate cooperative purchasing alliances. The Seminole County, Florida IFB for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2026) and the City of Tampa's sealed-bid solicitation for medical and first aid supplies for the Fire Department Rescue Division (26P00145, $700,000 estimated contract amount) represent direct procurement by local governments for operational health and emergency response. The Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescriptions (HHS0017013, posted April 3, 2026) signals state-level strategic interest in pharmacy supply chain optimization beyond traditional wholesaler and group purchasing organization channels.

Recent activity clusters in Florida and Texas, with broader multistate engagement through cooperative vehicles. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, response due March 26, 2026) spans multiple states including Oregon and seeks manufacturers to supply through three authorized wholesalers. Bidders on MMCAP contracts face a 3 percent administrative fee, must comply with current Good Manufacturing Practices and Drug Supply Chain Security Act requirements, and are subject to performance penalties of $200 to $1,500 per violation. The Tampa Fire Department procurement includes a 5 percent bid discount and sheltered-market designation for certified Small Local Business Enterprises, with an estimated contract value of $700,000. All pharmaceutical solicitations require vendor compliance with FDA requirements, insurance coverage minimums (including $5 million general liability on cooperative contracts), and expiration-date standards ensuring nine months to one year shelf life from acceptance or manufacture. No set-aside restrictions appear in the MMCAP or Texas HHS solicitations.